Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 12.41
-0.65 (-4.98%)
Apr 30, 2025, 3:00 PM CST
SHA:605199 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Net Income | 111.27 | 106.5 | 85.68 | 72.14 | 121.5 | 120.33 | Upgrade
|
| Depreciation & Amortization | 58.13 | 58.13 | 51.03 | 48.17 | 43.51 | 41.51 | Upgrade
|
| Other Amortization | 1.59 | 1.59 | 0.54 | 0.31 | 0.3 | 0.45 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.08 | 0.08 | 0.01 | 0.09 | 0.2 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.54 | 1.83 | 10.92 | 5.83 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.35 | -0.35 | -0.55 | -0.32 | -1.72 | -2.21 | Upgrade
|
| Provision & Write-off of Bad Debts | 21.92 | 21.92 | -0.23 | 3.23 | - | - | Upgrade
|
| Other Operating Activities | 78.63 | 33.35 | 22.89 | 12.65 | 11.41 | 13.36 | Upgrade
|
| Change in Accounts Receivable | -205.08 | -205.08 | -245.05 | -34.15 | -197.45 | -45.72 | Upgrade
|
| Change in Inventory | -59.96 | -59.96 | -6.06 | -28.79 | -35.84 | 16.7 | Upgrade
|
| Change in Accounts Payable | 73.58 | 73.58 | 326.9 | 20.38 | 64.07 | -5.17 | Upgrade
|
| Operating Cash Flow | 78.31 | 28.25 | 238.71 | 102.48 | 3.3 | 144.51 | Upgrade
|
| Operating Cash Flow Growth | -54.61% | -88.17% | 132.93% | 3005.68% | -97.72% | 354.49% | Upgrade
|
| Capital Expenditures | -228.52 | -489.2 | -392.32 | -137.62 | -59.42 | -58.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.06 | 0.08 | 0.26 | 0.11 | 0.08 | 0.01 | Upgrade
|
| Cash Acquisitions | - | -35.1 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | -19.54 | 0.11 | 1.72 | 3.06 | Upgrade
|
| Other Investing Activities | - | - | - | - | -20 | - | Upgrade
|
| Investing Cash Flow | -214.78 | -524.21 | -411.6 | -117.1 | -77.62 | -55.33 | Upgrade
|
| Long-Term Debt Issued | - | 1,140 | 686.02 | 464.22 | 242.27 | 90.83 | Upgrade
|
| Long-Term Debt Repaid | - | -552.39 | -507.52 | -260.53 | -123.74 | -119.74 | Upgrade
|
| Net Debt Issued (Repaid) | 191.44 | 588.08 | 178.5 | 203.68 | 118.53 | -28.91 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 173.12 | - | Upgrade
|
| Common Dividends Paid | -92.89 | -31.56 | -14.35 | -73.75 | -8 | -85.6 | Upgrade
|
| Other Financing Activities | -4.14 | -3.47 | - | 16.38 | -22.55 | 1.02 | Upgrade
|
| Financing Cash Flow | 94.41 | 553.06 | 164.15 | 146.32 | 261.1 | -113.49 | Upgrade
|
| Net Cash Flow | -42.06 | 57.1 | -8.74 | 131.7 | 186.79 | -24.31 | Upgrade
|
| Free Cash Flow | -150.22 | -460.95 | -153.61 | -35.14 | -56.12 | 86.12 | Upgrade
|
| Free Cash Flow Margin | -8.07% | -24.19% | -10.14% | -2.60% | -4.83% | 6.59% | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -1.17 | -0.38 | -0.09 | -0.15 | 0.24 | Upgrade
|
| Cash Income Tax Paid | 141.76 | 133.28 | 138.47 | 124.58 | 149.62 | 139.25 | Upgrade
|
| Levered Free Cash Flow | -37.21 | -523.43 | -206.31 | -52.48 | -129.2 | 26.16 | Upgrade
|
| Unlevered Free Cash Flow | -21.64 | -512.03 | -195.06 | -43.81 | -123.51 | 34.51 | Upgrade
|
| Change in Net Working Capital | -80.3 | 163.93 | -84.73 | 0.1 | 170.75 | 24.83 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.